BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9433446)

  • 1. Does use or withdrawal of long-acting beta 2-adrenoceptor induce desensitisation?
    Molimard M; Moore N; Begaud B
    Lancet; 1998 Jan; 351(9095):66-7. PubMed ID: 9433446
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics.
    Tan S; Hall IP; Dewar J; Dow E; Lipworth B
    Lancet; 1997 Oct; 350(9083):995-9. PubMed ID: 9329515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta 2-sympathomimetic drugs].
    Criée CP; Laier-Groeneveld G
    Internist (Berl); 1995 Sep; 36(9):918-23. PubMed ID: 7591618
    [No Abstract]   [Full Text] [Related]  

  • 4. Long acting beta2 agonists: are they safe?
    Wijesiriwardena B
    Ceylon Med J; 2006 Dec; 51(4):129-31. PubMed ID: 17461321
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous eformoterol and beta 2-receptor responsiveness.
    Sussman HS
    Br J Clin Pract Suppl; 1995 Sep; 81():16-7. PubMed ID: 8546889
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-acting bronchodilators for the control of asthma symptoms.
    Marshall GD
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):3-4. PubMed ID: 11206235
    [No Abstract]   [Full Text] [Related]  

  • 7. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance with beta 2-adrenoceptor agonists: time for reappraisal.
    Grove A; Lipworth BJ
    Br J Clin Pharmacol; 1995 Feb; 39(2):109-18. PubMed ID: 7742147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New viewpoints on therapy with beta-2-agonist-type bronchodilators and corticosteroids in bronchial asthma].
    Ionescu AA
    Pneumoftiziologia; 1992; 41(4):257-8. PubMed ID: 1364071
    [No Abstract]   [Full Text] [Related]  

  • 10. Salmeterol response and beta(2)-adrenergic receptor genotype.
    Jackson C; Lipworth B
    J Allergy Clin Immunol; 2007 Jul; 120(1):217-8; author reply 219-20. PubMed ID: 17399780
    [No Abstract]   [Full Text] [Related]  

  • 11. Filling in the gaps.
    Roberts J
    Nurs Stand; 2002 May 15-21; 16(35):27. PubMed ID: 12212333
    [No Abstract]   [Full Text] [Related]  

  • 12. beta-adrenergic receptor genotype and response to salmeterol.
    Wechsler ME; Israel E
    J Allergy Clin Immunol; 2007 Jul; 120(1):218-9; author reply 219-20. PubMed ID: 17399776
    [No Abstract]   [Full Text] [Related]  

  • 13. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
    Peters S
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilators: beta-agonists.
    Goldie RG; Lulich KM; Paterson JW
    Med J Aust; 1995 Jan; 162(2):100-2. PubMed ID: 7838013
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between beta-adrenoceptor gene polymorphisms and relative response to beta 2-agonists and anticholinergic drugs in Japanese asthmatic patients.
    Asano K; Yamada-Yamasawa W; Kudoh H; Matsuzaki T; Nakajima T; Hakuno H; Hiraoka R; Fukunaga K; Oguma T; Sayama K; Yamaguchi K; Nagabukuro A; Harada Y; Ishizaka A
    Respirology; 2010 Jul; 15(5):849-54. PubMed ID: 20546196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled beta 2-agonists and corticosteroids in the treatment of children with acute asthma attack.
    Volovitz B; Nussinovitch M
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):891-2. PubMed ID: 12455174
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta2-agonists for asthma: the pediatric perspective.
    Subbarao P; Ratjen F
    Clin Rev Allergy Immunol; 2006; 31(2-3):209-18. PubMed ID: 17085794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New possibilities for the beta-adrenoceptor agonist bronchodilator drugs.
    Waldeck B; Olsson OA; Svensson LA
    Agents Actions Suppl; 1988; 23():55-68. PubMed ID: 2902766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of long-acting beta-agonists in achieving asthma control.
    Drazen JM; O'Byrne PM
    N Engl J Med; 2009 Apr; 360(16):1671-2. PubMed ID: 19369675
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
    Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
    Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.